0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Hereditary Angioedema - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-353
Home | Category |Health |Health Conditions
Hereditary Angioedema Epidemiology Forecast to 2028

Hereditary Angioedema - Epidemiology Forecast to 2028

Code: DELV-Epid-353
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Hereditary Angioedema - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Hereditary Angioedema epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Hereditary Angioedema Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Hereditary Angioedema in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Hereditary Angioedema outlook. It also includes the explanation of changing trends of epidemiology outlining the Hereditary Angioedema scenario.

Hereditary Angioedema Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Hereditary Angioedema thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Hereditary Angioedema explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Hereditary Angioedema Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Hereditary Angioedema

Key assessments
• Patient Segmentation in Hereditary Angioedema
• Hereditary Angioedema Risk & Burden
• Factors driving growth in a specific Hereditary Angioedema patient population

1. Report Introduction
2. Hereditary Angioedema Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Hereditary Angioedema in 2016
2.2. Patient Share Distribution of Hereditary Angioedema in 2028
3. Disease Background and Overview: Hereditary Angioedema
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hereditary Angioedema in 7MM
4.3. Total Prevalent/ Incident Patient Population of Hereditary Angioedema in 7MM – By Countries
5. Epidemiology of Hereditary Angioedema by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.1.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.1.4. Sex- Specific Cases of the Hereditary Angioedema *
5.1.5. Diagnosed Cases of the Hereditary Angioedema
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.4.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.4.4. Sex- Specific Cases of the Hereditary Angioedema *
5.4.5. Diagnosed Cases of the Hereditary Angioedema
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.5.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.5.4. Sex- Specific Cases of the Hereditary Angioedema *
5.5.5. Diagnosed Cases of the Hereditary Angioedema
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.6.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.6.4. Sex- Specific Cases of the Hereditary Angioedema *
5.6.5. Diagnosed Cases of the Hereditary Angioedema
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.7.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.7.4. Sex- Specific Cases of the Hereditary Angioedema *
5.7.5. Diagnosed Cases of the Hereditary Angioedema
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.8.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.8.4. Sex- Specific Cases of the Hereditary Angioedema *
5.8.5. Diagnosed Cases of the Hereditary Angioedema
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.9.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.9.4. Sex- Specific Cases of the Hereditary Angioedema *
5.9.5. Diagnosed Cases of the Hereditary Angioedema
6. Unmet Needs of the Hereditary Angioedema
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM
Table 2: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hereditary Angioedema in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Hereditary Angioedema in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Hereditary Angioedema in United States (2016-2028)*
Table 6: Diagnosed Cases of the Hereditary Angioedema in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Hereditary Angioedema in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Hereditary Angioedema in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Hereditary Angioedema in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Hereditary Angioedema in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Hereditary Angioedema in France (2016-2028)
Table 12: Sub-Type Specific cases of the Hereditary Angioedema in France (2016-2028) *
Table 13: Sex- Specific Cases of the Hereditary Angioedema in France (2016-2028) *
Table 14: Diagnosed Cases of the Hereditary Angioedema in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Hereditary Angioedema in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Hereditary Angioedema in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Hereditary Angioedema in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Hereditary Angioedema in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Hereditary Angioedema in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Hereditary Angioedema in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Hereditary Angioedema in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Hereditary Angioedema in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Hereditary Angioedema in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Hereditary Angioedema in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Hereditary Angioedema in UK (2016-2028) *
Table 26: Diagnosed Cases of the Hereditary Angioedema in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Hereditary Angioedema in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Hereditary Angioedema in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Hereditary Angioedema in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Hereditary Angioedema in Japan (2016-2028)

Listof figures :

Figure 1: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hereditary Angioedema in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Hereditary Angioedema in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Hereditary Angioedema in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Hereditary Angioedema in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Hereditary Angioedema in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Hereditary Angioedema in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Hereditary Angioedema in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Hereditary Angioedema in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Hereditary Angioedema in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Hereditary Angioedema in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Hereditary Angioedema in France (2016-2028) *
Figure 14: Diagnosed Cases of the Hereditary Angioedema in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Hereditary Angioedema in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Hereditary Angioedema in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Hereditary Angioedema in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Hereditary Angioedema in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Hereditary Angioedema in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Hereditary Angioedema in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Hereditary Angioedema in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Hereditary Angioedema in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Hereditary Angioedema in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Hereditary Angioedema in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Hereditary Angioedema in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Hereditary Angioedema in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Hereditary Angioedema in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Hereditary Angioedema in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Hereditary Angioedema in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Hereditary Angioedema in Japan (2016-2028)

DelveInsight's "Hereditary Angioedema - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Hereditary Angioedema epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Hereditary Angioedema Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Hereditary Angioedema in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Hereditary Angioedema outlook. It also includes the explanation of changing trends of epidemiology outlining the Hereditary Angioedema scenario.

Hereditary Angioedema Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Hereditary Angioedema thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Hereditary Angioedema explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Hereditary Angioedema Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Hereditary Angioedema

Key assessments
• Patient Segmentation in Hereditary Angioedema
• Hereditary Angioedema Risk & Burden
• Factors driving growth in a specific Hereditary Angioedema patient population

Read More

1. Report Introduction
2. Hereditary Angioedema Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Hereditary Angioedema in 2016
2.2. Patient Share Distribution of Hereditary Angioedema in 2028
3. Disease Background and Overview: Hereditary Angioedema
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hereditary Angioedema in 7MM
4.3. Total Prevalent/ Incident Patient Population of Hereditary Angioedema in 7MM – By Countries
5. Epidemiology of Hereditary Angioedema by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.1.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.1.4. Sex- Specific Cases of the Hereditary Angioedema *
5.1.5. Diagnosed Cases of the Hereditary Angioedema
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.4.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.4.4. Sex- Specific Cases of the Hereditary Angioedema *
5.4.5. Diagnosed Cases of the Hereditary Angioedema
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.5.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.5.4. Sex- Specific Cases of the Hereditary Angioedema *
5.5.5. Diagnosed Cases of the Hereditary Angioedema
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.6.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.6.4. Sex- Specific Cases of the Hereditary Angioedema *
5.6.5. Diagnosed Cases of the Hereditary Angioedema
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.7.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.7.4. Sex- Specific Cases of the Hereditary Angioedema *
5.7.5. Diagnosed Cases of the Hereditary Angioedema
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.8.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.8.4. Sex- Specific Cases of the Hereditary Angioedema *
5.8.5. Diagnosed Cases of the Hereditary Angioedema
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hereditary Angioedema
5.9.3. Sub-Type Specific cases of the Hereditary Angioedema *
5.9.4. Sex- Specific Cases of the Hereditary Angioedema *
5.9.5. Diagnosed Cases of the Hereditary Angioedema
6. Unmet Needs of the Hereditary Angioedema
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

Read More

List of Tables :

Table 1: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM
Table 2: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hereditary Angioedema in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Hereditary Angioedema in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Hereditary Angioedema in United States (2016-2028)*
Table 6: Diagnosed Cases of the Hereditary Angioedema in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Hereditary Angioedema in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Hereditary Angioedema in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Hereditary Angioedema in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Hereditary Angioedema in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Hereditary Angioedema in France (2016-2028)
Table 12: Sub-Type Specific cases of the Hereditary Angioedema in France (2016-2028) *
Table 13: Sex- Specific Cases of the Hereditary Angioedema in France (2016-2028) *
Table 14: Diagnosed Cases of the Hereditary Angioedema in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Hereditary Angioedema in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Hereditary Angioedema in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Hereditary Angioedema in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Hereditary Angioedema in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Hereditary Angioedema in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Hereditary Angioedema in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Hereditary Angioedema in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Hereditary Angioedema in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Hereditary Angioedema in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Hereditary Angioedema in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Hereditary Angioedema in UK (2016-2028) *
Table 26: Diagnosed Cases of the Hereditary Angioedema in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Hereditary Angioedema in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Hereditary Angioedema in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Hereditary Angioedema in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Hereditary Angioedema in Japan (2016-2028)

Listof figures :

Figure 1: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hereditary Angioedema in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hereditary Angioedema in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Hereditary Angioedema in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Hereditary Angioedema in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Hereditary Angioedema in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Hereditary Angioedema in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Hereditary Angioedema in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Hereditary Angioedema in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Hereditary Angioedema in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Hereditary Angioedema in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Hereditary Angioedema in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Hereditary Angioedema in France (2016-2028) *
Figure 14: Diagnosed Cases of the Hereditary Angioedema in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Hereditary Angioedema in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Hereditary Angioedema in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Hereditary Angioedema in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Hereditary Angioedema in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Hereditary Angioedema in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Hereditary Angioedema in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Hereditary Angioedema in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Hereditary Angioedema in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Hereditary Angioedema in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Hereditary Angioedema in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Hereditary Angioedema in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Hereditary Angioedema in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Hereditary Angioedema in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Hereditary Angioedema in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Hereditary Angioedema in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Hereditary Angioedema in Japan (2016-2028)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global Negative Pressure Wound Therapy Market Research Report 2021
Global Negative Pressure Wound Therapy Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-6C4528
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Paclitaxel Injection Market Research Report 2021
Global Paclitaxel Injection Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-5J4435
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Myotonic Dystrophy Medication Market Size Status and Forecast 2021 2027
Global Myotonic Dystrophy Medication Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10R4400
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Transthyretin amyloid cardiomyopathy ATTR CM Treatment Market Size Status and Forecast 2021 2027
Global Transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-0N4529
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0